Wolfgang A Schulz

17PUBLICATIONS
32CO-AUTHORS
Molecular targetsCancer cell biologyCancer geneticsBiologically active moleculesCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (17)

|Feb 15, 2022
Epigenetics in the Diagnosis and Therapy of Malignant Melanoma.

Simeon Santourlidis, Wolfgang A Schulz, Marcos J Araúzo-Bravo

|Dec 10, 2021
Alterations of Chromatin Regulators in the Pathogenesis of Urinary Bladder Urothelial Carcinoma.

Michèle J Hoffmann, Wolfgang A Schulz

|Apr 03, 2021
Epigenetic Treatment of Urothelial Carcinoma Cells Sensitizes to Cisplatin Chemotherapy and PARP Inhibitor Treatment.

Sophia Thy, Alexandra Hommel, Sarah Meneceur

|Mar 06, 2021
Downregulation of Cell Cycle and Checkpoint Genes by Class I HDAC Inhibitors Limits Synergism with G2/M Checkpoint Inhibitor MK-1775 in Bladder Cancer Cells.

Michèle J Hoffmann, Sarah Meneceur, Katrin Hommel

|Dec 16, 2020
Many Different LINE-1 Retroelements Are Activated in Bladder Cancer.

Patcharawalai Whongsiri, Wolfgang Goering, Tobias Lautwein

|Jul 09, 2020
In Vitro Assessment of the Genotoxic Hazard of Novel Hydroxamic Acid- and Benzamide-Type Histone Deacetylase Inhibitors (HDACi).

Annabelle Friedrich, Ann-Sophie Assmann, Lena Schumacher

Pageof 3

Frequent Collaborators

11 joint publications

Michèle J Hoffmann

9 joint publications

Günter Niegisch

5 joint publications

Patrick Petzsch

4 joint publications

Karl Köhrer